Anavex Life Sciences Corp (AVXL)

[gbrown6332]

Interesting read posted on Investors Village. Article questioning the thundering pharma herd that's still pursuing amyloid reduction as a primary ALZ solution. Documents medical community surprise at the broad Biogen Aduhelm approval from the FDA with a projected $56K per patient annual cost.

https://www.washingtonpost.com/health/2021/07/05/aduhelm-new-alzheimers-drug-amyloid/

The FDA motto - A puzzle inside a riddle wrapped in an enigma.

G.B.